Celldex Therapeutics (CLDX)
(Real Time Quote from BATS)
$41.37 USD
+0.16 (0.39%)
Updated May 9, 2024 11:44 AM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.58 |
EPS Last Quarter | -0.56 |
Last EPS Surprise | 16.42% |
ABR | 1.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.45 |
Next Year | -2.92 |
EPS (TTM) | -2.59 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.19M | 1.21M | 2.87M | 4.30M |
# of Estimates | 2 | 2 | 3 | 2 |
High Estimate | 1.38M | 1.42M | 5.20M | 5.40M |
Low Estimate | 1.00M | 1.00M | 0.20M | 3.20M |
Year ago Sales | 0.27M | 1.52M | 6.88M | 2.87M |
Year over Year Growth Est. | 340.74% | -20.39% | -58.37% | 50.03% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.58 | -0.60 | -2.45 | -2.92 |
# of Estimates | 3 | 3 | 6 | 4 |
Most Recent Consensus | -0.69 | -0.74 | -2.84 | -3.17 |
High Estimate | -0.51 | -0.54 | -1.90 | -2.67 |
Low Estimate | -0.63 | -0.65 | -2.90 | -3.42 |
Year ago EPS | -0.65 | -0.81 | -2.66 | -2.45 |
Year over Year Growth Est. | 10.77% | 25.93% | 7.89% | -18.95% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 3 | 3 | 3 | 3 |
Up Last 30 Days | 3 | 3 | 3 | 3 |
Up Last 60 Days | 3 | 3 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.58 | -0.60 | -2.45 | -2.92 |
7 Days Ago | -0.68 | -0.73 | -2.85 | -3.36 |
30 Days Ago | -0.68 | -0.73 | -2.85 | -3.36 |
60 Days Ago | -0.68 | -0.73 | -2.93 | -3.36 |
90 Days Ago | -0.72 | -0.73 | -3.31 | -4.02 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.58 | -0.60 | -2.25 | -2.75 |
Zacks Consensus Estimate | -0.58 | -0.60 | -2.45 | -2.92 |
Earnings ESP | 0.00% | 0.00% | 8.49% | 5.74% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.56 | -0.57 | -0.81 | -0.65 | NA |
Estimate | -0.67 | -0.76 | -0.67 | -0.65 | NA |
Difference | 0.11 | 0.19 | -0.14 | 0.00 | 0.04 |
Surprise | 16.42% | 25.00% | -20.90% | 0.00% | 5.13% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more